NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR)
CUSIP: 640268108
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 28,811,441
- Total 13F shares
- 6,448
- Share change
- -123,482,951
- Total reported value
- $52,906
- Price per share
- $25.84
- Number of holders
- 7
- Value change
- -$84,345,665
- Number of buys
- 2
- Number of sells
- 154
Quarterly Holders Quick Answers
What is CUSIP 640268108?
CUSIP 640268108 identifies NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 640268108:
Top shareholders of NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP |
3/4/5
13D/G
|
10%+ Owner |
1.1%
from 13D/G
|
18,344,000
|
$32,635,810 | — | 10 May 2024 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
1.6%
from 13D/G
|
15,707,325
|
$10,680,981 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
43%
|
12,309,688
|
$8,370,588 | — | 31 Mar 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
27%
|
7,789,051
|
$5,296,555 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
25%
|
7,301,734
|
$4,961,000 | — | 31 Mar 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13D/G
13F
|
Company |
3.6%
|
6,650,000
|
$4,921,000 | $0 | 31 Dec 2024 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
19%
|
5,354,586
|
$3,641,119 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
16%
|
4,701,781
|
$3,197,211 | — | 31 Mar 2025 | |
| Almitas Capital LLC |
13F
|
Company |
16%
|
4,610,872
|
$3,135,393 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
14%
|
4,009,124
|
$2,727,024 | — | 31 Mar 2025 | |
| TCG Crossover Management, LLC |
13F
|
Company |
14%
|
4,000,000
|
$2,720,000 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
13%
|
3,691,878
|
$2,510,477 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
13%
|
3,640,851
|
$2,462,672 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
11%
|
3,258,290
|
$2,215,637 | — | 31 Mar 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
10%
|
3,007,928
|
$2,045,391 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
7.9%
|
2,288,802
|
$1,556,385 | — | 31 Mar 2025 | |
| Exome Asset Management LLC |
13F
|
Company |
7.7%
|
2,232,453
|
$1,518,068 | — | 31 Mar 2025 | |
| 22NW, LP |
13F
|
Company |
7.6%
|
2,191,750
|
$1,490,390 | — | 31 Mar 2025 | |
| MACKENZIE FINANCIAL CORP |
13F
|
Company |
5.8%
|
1,658,745
|
$1,127,947 | — | 31 Mar 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
5.5%
|
1,579,528
|
$1,074,079 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
5%
|
1,435,096
|
$975,865 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
5%
|
1,434,457
|
$975,431 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
4.9%
|
1,420,542
|
$965,969 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
4.9%
|
1,417,166
|
$963,674 | — | 31 Mar 2025 | |
| Union Square Park Capital Management, LLC |
13F
|
Company |
3.8%
|
1,100,000
|
$748,000 | — | 31 Mar 2025 | |
| Monaco Asset Management SAM |
13F
|
Company |
3.7%
|
1,068,899
|
$726,851 | — | 31 Mar 2025 | |
| Altium Capital Management LLC |
13F
|
Company |
3.6%
|
1,051,379
|
$714,938 | — | 31 Mar 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
3.6%
|
1,036,000
|
$704,480 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3.4%
|
992,100
|
$674,628 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
3%
|
850,115
|
$578,078 | — | 31 Mar 2025 | |
| CM Management, LLC |
13F
|
Company |
2.8%
|
800,000
|
$544,000 | — | 31 Mar 2025 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
670,149
|
$455,701 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
2.2%
|
623,218
|
$423,788 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
2%
|
584,117
|
$397,200 | — | 31 Mar 2025 | |
| Peapod Lane Capital LLC |
13F
|
Company |
2%
|
577,238
|
$392,522 | — | 31 Mar 2025 | |
| Deuterium Capital Management, LLC |
13F
|
Company |
1.9%
|
560,235
|
$380,960 | — | 31 Mar 2025 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
1.9%
|
557,222
|
$378,911 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.9%
|
557,207
|
$378,901 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.8%
|
531,362
|
$361,326 | — | 31 Mar 2025 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
506,446
|
$344,383 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.7%
|
491,246
|
$334,047 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.7%
|
491,195
|
$334,013 | — | 31 Mar 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
432,739
|
$294,263 | — | 31 Mar 2025 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
1.4%
|
412,379
|
$280,418 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.4%
|
393,293
|
$267,439 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.3%
|
373,654
|
$254,538 | — | 31 Mar 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
1.3%
|
368,304
|
$250,447 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
1.2%
|
351,143
|
$238,777 | — | 31 Mar 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
1.2%
|
343,935
|
$233,000 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
1.1%
|
327,310
|
$222,570 | — | 31 Mar 2025 |
Institutional Holders of NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) as of Q2 2025
As of 30 Jun 2025,
NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,448 shares.
The largest 7 holders included
IFP Advisors, Inc, Parallel Advisors, LLC, EverSource Wealth Advisors, LLC, Rise Advisors, LLC, AllSquare Wealth Management LLC, LRI Investments, LLC, and HUNTINGTON NATIONAL BANK.
This page lists
7
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
156
Q2 2025 holders
7
Holder diff
-149
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.